Australian chromatography solutions producer, IonOpticks, has announced that it plans to introduce its new TS product range to the US market.
The company said its new TS range was developed as a simple plug-and-play, fully integrated heating and source solution for Thermo Scientific mass spectrometer users, who have previously only been able to access the results achievable with IonOpticks Aurora Series columns by creating their own interface.
“Researchers can now easily unlock the full potential of their mass specs through the launch of our new TS range. Thermo Orbitraps have been cited in roughly 85% of all publications related to proteomics in the last decade, so we’re excited to make our famed Aurora Series products easily accessible to this significant portion of the mass spec community,” said Xavier Perronnet, the managing director at IonOpticks.
“We’re excited to be attending US HUPO, to meet with our peers and showcase how the TS, combined with our Aurora Series columns, can provide Thermo mass spec users the ability to supercharge the sensitivity of their existing instruments. Our columns enable researchers to delve deeper into their samples than ever before,” he said.
The company said its TS range was developed following the release of the Aurora Frontier - the first-ever column to routinely generate over 10,000 protein identifications on a Thermo mass spectrometer - from a single sample and single species.
“The results that have been achieved with our Aurora Frontier have been outstanding and we’re proud to continue to develop products that enable us to ensure access to these gains is equal for all researchers,” said Dr Jarrod Sandow, the head of Product Development at IonOpticks.
“Thermo users continue to be top customers of our products, so we’ve worked hard behind the scenes to ensure these users can easily boost the performance of their existing instruments through a simple all-in-one heating and source integration system. One that requires no complex installation and is ready to use straight out of the box,” added Dr Sandow.